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This is one paper in a three-part series that
sets out how evidence should be translated
into guidance to inform policies on health
systems and improve the delivery of clinical
and public health interventions.
Introduction
Policies about health systems can have
profound impacts on citizens, patients,
health professionals, and managers. For
physicians, for example, the impacts can
include changing their scope of practice (a
governance arrangement), how they are
paid (a financial arrangement), where they
provide care (a delivery arrangement), and
how their practices are supported in
providing the types of care that citizens
and patients value (an implementation
strategy). Contextual factors are extremely
important in shaping decisions about
health systems, and policy makers have
to work through all the pros and cons of
different options before developing new
policies on health systems.
In this paper, which is the second of a
three-part series on health systems guidance
[1,2], by considering issues raised during
meetings of the World Health Organiza-
tion’s (WHO) Task Force on Developing
Health Systems Guidance (Box 1), we:
N Explore the links between health systems
guidance development and policy devel-
opment at global and national levels;
N Examine the range of factors that can
influence policy development.
The first article in the series makes a case
for developing guidance to inform decisions
on health systems-level questions based on
an analysis of strategic health sector
documents, explores specific challenges in
producing such guidance, and identifies
options for addressing these challenges [1].
The third paper focuses on assessing how
much confidence can be placed on health
systems research evidence in both guidance
and policy development processes [2].
Here and in the other two papers in the
series, we rely on a set of key definitions
(Text S1). While the definitions of health
systems and health systems interventions
may be familiar to many, the definition of
health systems guidance differs significant-
ly from the definition of clinical guidelines
[3], both in its focus on including options
for consideration and in its focus on using
guidance to assist decision-making in a
range of settings. The importance of
contextual factors in shaping decisions
about health systems means that health
systems guidance should include informa-
tion about what is known about the pros
and cons of different options, the factors
that will likely influence decisions about
the options in different settings, and the
tools that can support local guidance or
policy development processes. A policy
brief can be used to provide background
evidence to inform a policy dialogue
among stakeholders [4,5], which can in
turn result in the articulation of the
preferred policy option(s).
Importantly, in our definitions of both
health systems guidance and policy briefs
(Text S1) and throughout this paper, we
emphasize the importance of being sys-
tematic and of involving all stakeholders.
The recent World Health Assembly
resolution on guidance for health system
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policies gives much needed attention to
the issue of health systems guidance [6,7].
However, the resolution contains only two
uses of the phrase ‘‘evidence-based’’ (one
for the assessment of a country’s health
and health system problems, the other for
responses to evolving problems) and one
call for ‘‘involv[ing] all relevant stake-
holders.’’ Moreover, the resolution and
related materials are largely silent on the
need to follow systematic processes for
evidence synthesis and stakeholder en-
gagement.
Links between Guidance
Development and Policy
Development
Economy of scale and efficiency consid-
erations at the global level, and resource
and capacity constraints at the national
level, mean that a division of labour
among global guidance developers, global
policy developers, national guidance de-
velopers, and national policy developers is
needed to support evidence-informed pol-
icy-making about health systems (Figure 1).
All these groups would help to set
priorities and provide feedback (double-
headed arrows in Figure 1).
The first group—a panel charged with
developing guidance about health systems
at the global level similar to the panels
convened by WHO to address specific
issues—could likely best add value by
developing health systems guidance and
by supporting its use in three types of
processes:
N Policy development at the global level
(where applicable);
N Guidance development at the national
level;
N Policy development at the national
level.
Policy Development at the Global
Level
International organizations like WHO
and the World Bank, global initiatives like
the Global Alliance for Vaccines and
Immunization and the Global Fund to
Fight AIDS, Tuberculosis and Malaria,
and many bilateral initiatives and some
very large multinational nongovernmental
organizations (NGOs) could draw on the
global guidance to inform decisions within
their respective remits. Such decisions may
be about how the organization invests its
money directly (e.g., bulk-purchasing ar-
rangements) or about how it attaches
conditionalities to funds invested in related
areas (e.g., staffing in HIV clinics). For
some of these organizations and initiatives,
making policy decisions about health
systems is a relatively new area that lies
outside their normally perceived remit, but
the impacts of their involvement in making
policy decisions on health systems could be
profound given their scale of funding.
Guidance Development at the
National Level
A national Evidence-Informed Policy
Network (EVIPNet, see Text S1) spon-
sored by government or a guidance panel
appointed by government (or other groups
provided their members have the skills and
experiences for such work) could draw on
the global guidance to develop a country-
specific policy brief that contextualizes the
health system problem, options for ad-
dressing the problem, key implementation
considerations, and (possibly) monitoring
and evaluation considerations. The policy
brief could draw on context-specific data
and research evidence in each of these
domains and could take into consideration
any global decisions that might be consid-
ered binding on the country. A recent
Summary Points
N Contextual factors are extremely important in shaping decisions about health
systems, and policy makers need to work through all the pros and cons of
different options before adopting specific health systems guidance.
N A division of labour between global guidance developers, global policy
developers, national guidance developers, and national policy developers is
needed to support evidence-informed policy-making about health systems.
N A panel charged with developing health systems guidance at the global level
could best add value by ensuring that its output can be used for policy
development at the global and national level, and for guidance development at
the national level.
N Rigorous health systems analyses and political systems analyses are needed at
the global and national level to support guideline and policy development.
N Further research is needed into the division of labour in guideline development
and policy development and on frameworks for supporting system and political
analyses.
N This is the second paper in a three-part series in PLoS Medicine on health
systems guidance.
Box 1. The Task Force on Developing Health Systems Guidance
To improve how it responds to requests for guidance on health systems, WHO
established the Task Force on Developing Health Systems Guidance in 2009.
Briefly:
N WHO selected the 20 members of this Task Force to ensure diversity in terms of
skills and experience in four broad domains—health policy and systems
research (30% of the panel members), systematic reviews (55%), national
deliberative processes (20%), and guidance development (40%)—and in terms
of gender (25% female) and current base in a low- and middle-income country
(30%).
N The Task Force provided input to the development of a Handbook for
Developing Health Systems Guidance and to the identification of broader issues
that warranted further dialogue and debate [12].
N As part of this process, the Task Force reviewed approaches to developing
clinical guidelines and the instruments used as well as the broader literature on
the four broad domains listed above, which were synthesized by the Handbook
developers.
N The Task Force suggested ways in which some of the approaches and
instruments used to develop clinical guidelines could be adapted for use in the
development of health systems guidance and indicated where there were
important differences between these two types of guidance.
The writing group for this paper further considered the issues raised in these
discussions and produced a first draft of the manuscript for comment by the Task
Force. This paper and the other two in the series [1,2] were finalised after several
iterations of comments by the Task Force and external reviewers.
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example of such an effort is the policy
briefs that were developed to scale up the
widespread use of artemisinin-based com-
bination therapy to treat malaria. In this
instance, global guidance spurred (but did
not fully support) the national guidance
development processes that EVIPNets
undertook in several African countries
and regions [8].
An EVIPNet could also convene a
policy dialogue that allows the data and
research evidence contained in the policy
brief to inform and be considered along-
side the views, experiences, and tacit
knowledge of those who will be involved
in, or affected by, future decisions about
the health system problem [5]. The
evidence brief and dialogue summary
could then be used by the national
government to inform a decision.
Global decisions that might be consid-
ered in national guidance development
processes include the normative standards
that WHO member states collectively
endorse at the World Health Assembly
and agree to abide by in their respective
countries. However, worryingly, a review
of the statements made by the World Bank
and WHO on topics addressed by the
World Health Assembly between 2000
and 2003 (including three broad health
systems topic areas) revealed that these
statements are rarely consistent with the
direction and the nature of effect claims
from systematic reviews, which suggests
that there is significant potential for
improvement in how these organizations
use or report the use of synthesized
research evidence in their policy-develop-
ment processes [9].
Policy Development at the National
Level
A national government could make
decisions for its country by drawing on
the health systems guidance produced at
the global level and/or a policy brief
produced at the national level (with or
without the summary of a policy dialogue
that was informed by the policy brief) and
by keeping in mind any global decisions
that it acknowledges as binding on itself.
The national government may choose to
convene one or more policy dialogues or
use other stakeholder-engagement ap-
proaches to support its decision-making
and to reach agreement among stakehold-
ers, ideally informed by the policy brief and
supported by relevant tools highlighted in
the guidance produced at the global level.
Will This Proposed Division of
Labour Work?
We suggest that this proposed division
of labour should be explored retrospec-
tively by looking at several cases where
health systems guidance has been devel-
oped at the global level and examining
how the process could have unfolded
differently with a view to refining the
process. The division of labour could also
be examined prospectively by examining
cases where guidance is being developed at
the global level and EVIPNets (among
others) are drawing on this guidance to
develop national policy briefs and convene
national policy dialogues. Additional in-
sights could be derived by examining the
lessons learned in the field of health
technology assessment where a similar
need for a division of labour has been
documented, albeit mainly at the level of
drugs, devices, and other technologies
[10].
Factors That Can Influence
Policy Development
The final stage in the process of health
systems policy development is the prepa-
ration of a document (or documents)
produced within a national government
to support decision-making by that gov-
ernment. A range of names might be
applied to the document(s), which is
ideally informed by global guidance, a
national policy brief, and other inputs, but
for simplicity, we refer to this decision-
support document as a policy proposal.
Figure 1. Potential links between guidance and policy development at global and national levels.
doi:10.1371/journal.pmed.1001186.g001
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The health systems guidance (which
emphasizes global evidence), policy brief
(which emphasizes global and national
research evidence), and policy proposal
(which emphasizes the many consider-
ations supporting a preferred course of
action) all need to synthesize what is
known and not known about the pros
and cons of the options under consider-
ation. They also all need to assess the
factors that can influence the choice,
implementation, and monitoring and eval-
uation of these options in different settings
(or in the case of the policy brief and policy
proposal, at least refer to the synthesis
contained in the guidance and policy brief,
respectively, when they exist). While
varying in emphasis, each of these docu-
ments would ideally document:
N Key features of an assessment about
how to address a health system prob-
lem;
N Key features of a health system (or
health systems) that can influence
decision-making about how to address
a health system problem;
N Key features of a political system (or
political systems) that can influence
decision-making about how to address
a health system problem.
Key Features of an Assessment
about How to Address a Health
System Problem
An assessment about how to address a
health system problem requires working
through the underlying problem, the
appropriate options to address the prob-
lem, and implementation issues (see Table
S1). Much of what is known and not
known about each of these areas can be
derived from available data and research
evidence. Health systems guidance that is
produced at the global level can present
overall summaries of the answers to these
questions and identify patterns in the
variation in these answers across health
systems and political systems. Synthesized
research evidence about health systems is
increasingly available, and initiatives to
make it easier to find and use evidence can
support guidance development at the
global level (e.g., Health Systems Evidence
at http://www.healthsystemsevidence.org,
which is now available in Arabic, Chinese,
English, French, Portuguese, Russian, and
Spanish). A policy brief produced at the
national level can supplement the data and
research evidence contained in global
health systems guidance with local data
and research evidence in order to present
as clearly as possible what is known about
how to address a health system problem in
a particular country.
Key Features of Health Systems That
Can Influence Decision-Making
about How to Address a Health
System Problem
An assessment of the key features of
health systems that can influence decision-
making about how to address a health
system problem involves working through
existing governance, financial, and deliv-
ery arrangements to determine which
arrangements might help or hinder any
options being considered (Table 1). A new
health systems intervention such as pay-
for-performance might ‘‘fit’’ into one
health system, but the same intervention
or part of the health system might require
significant adjustment or complementary
interventions to fit into a system where
performance data are not collected sys-
tematically. Moreover, any new health
systems intervention may have unantici-
pated consequences for the existing health
system arrangements in which it is intro-
duced, for example, by removing incen-
tives for some types of activity.
Some of what is known and not known
about the key health system arrangements
can be derived from available data and
research evidence. Health systems guid-
ance that is produced at the global level
can present overall summaries of what is
known about which arrangements are key
for achieving the desired impacts in
different health system contexts. A policy
brief produced at the national level can
enrich these summaries with local data
and research evidence in order to present
as clearly as possible what is known about
how existing health system arrangements
may influence the selection and imple-
mentation of options. In this way, policy-
making about health systems can be
informed by a good understanding of the
system-level context for an option and the
range of its potential desired and unde-
sired system-wide effects, and any adapta-
tion and re-design of the option (and
potentially other health system arrange-
ments) that is needed to optimize synergies
among health system elements.
Key Features of Political Systems
That Can Influence Decision-Making
about How to Address a Health
System Problem
An assessment of the key features of a
political system that can influence deci-
sion-making about how to address a health
system problem involves working through
the institutions, interests, and ideas that
currently drive decision-making, as well as
the ‘‘external factors’’ that can open
windows of opportunity to introduce
change (Table 2). As above, globally
produced health systems guidance can
ideally present overall summaries about
what is known about which features are
key and identify patterns in the variation
of these features across health systems and
political systems. A policy brief produced
at the national level can enrich the data
and research evidence from health systems
guidance with local data and research
evidence. Moreover, a policy dialogue
conducted at the national level can further
enrich the available data and research
evidence with local views, experiences,
and tacit knowledge about how the
political system really works and which
system features are most important for the
issue at hand.
How Do These Assessments Relate
to One Another and to Other
Approaches?
These three types of assessment are
clearly interrelated. For example, empirical
research has shown that an option is often
deemed an appropriate solution if it is
technically feasible (which can come from
Tables S1 and 1), fits with dominant values
and the current national/provincial mood
(which can come from Table 2), and is
acceptable in terms of affordability (which
can come from Tables S1 and 2) and likely
political support or opposition (which can
come from Table 2) [11]. The Handbook for
Developing Health Systems Guidance sets out an
approach that focuses on the intervention
as tested (e.g., costs, appropriateness, ease
of implementation), requirements in rela-
tion to implementers or facilitators (e.g.,
credibility, skills, experience), requirements
in terms of users of the interventions (e.g.,
capacity, training), and factors related to
the context (e.g., political, socioeconomic,
rights), which again can be traced to Tables
S1, 1, and 2 [12]. Unpacking these
assessments further, as we have done here,
can help to provide a more systematic and
transparent assessment.
As we discuss in the next paper, existing
approaches to grading the quality of
recommendations about clinical options
will likely require significant modification
for use in a health system context [2]. The
GRADE approach [13], for example,
focuses only on two of the system-level
factors that we have described—‘‘values
and preferences’’ and ‘‘feasibility’’—but
there are many more factors that will
influence the choice of options for ad-
dressing a health system problem in
different settings (as well as the implemen-
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tation and the monitoring and evaluation
of the preferred option). Also, the GRADE
approach is typically executed by experts,
and, while it can inform and complement
policy dialogues and other stakeholder-
engagement processes, it cannot substitute
for these processes in the assessment of
system factors.
Conclusions
Our proposed division of labour links
guidance development at the global level
with policy development at the national
level. Balancing a broad range of system
and political considerations to come to a
reasoned judgment about how to address a
health system problem is arguably the
purview of those who have been given the
accountability to make decisions about
health systems, whether democratically
elected or appointed. Typically, these
policy makers are located at the national
level. Our examination of the range of
factors that can influence policy develop-
ment (and that can be flagged for
consideration in health systems guidance)
highlights the need for rigorous system and
political analyses in policy briefs at the
national level. These analyses can be
supported at the global level by health
systems guidance that presents overall
summaries about what is known about
which health and political system features
help and hinder particular options. These
analyses can also be aided by the frame-
works presented in Tables S1, 1, and 2, by
the SUPporting POlicy Relevant Trials
(SUPPORT) tools [14]—a set of tools that
can be used by people involved in finding
and using research evidence to support
evidence-informed health policy-mak-
ing—and by a range of other approaches
such as the evidence synthesis and grading
approaches presented in the other two
papers in the series [1,2] and the decision
trees, system modeling, and evaluation
frameworks presented in the Handbook for
Developing Health Systems Guidance [12].
Those involved in policy development at
the national level will need to, as repre-
sentatives of member states of WHO, push
for change at the global level if guidance
development in the area of health systems
Table 1. Key features of a health system that can influence decision-making about how to address a health system problem.
Key Features Examples
Governance arrangements
N Policy authority N National ministry sets policy directions for the health system but sub-national (e.g., provincial) ministries and
private organizations can accept, adapt, or reject them
N National and provincial ministries only weakly enforce anti-corruption policies
N Organizational authority N Private for-profit companies own most hospitals in urban centres, whereas religious charities own most hospitals
in rural areas
N A national network of pharmacies acts as a de facto monopoly
N Commercial authority N Limited regulation of patents, prices, and marketing of diagnostic tests
N Strong safeguards against the production and sale of counterfeit medicines
N Professional authority N Only physicians have the regulatory authority to diagnose and prescribe
N Mandatory continuing professional development of health professionals
N Consumer and stakeholder involvement N Half of the seats on all health system advisory councils are reserved for consumers
N Large non-governmental organizations participate in key ministry planning meetings
Financial arrangements
N Financing systems N Mandatory participation in a private or community-based insurance scheme
N Reliance on donor contributions for major infectious disease programs but insufficient funding from any source for
non-communicable disease programs
N Funding organizations N Ministry uses global budgets to fund public and private not-for-profit hospitals
N Clinics incur a financial penalty if they fail to achieve performance targets, one of which is high consumer
satisfaction ratings
N Remunerating providers N All hospital-based personnel are paid by salary
N Community health workers receive a bonus if they achieve performance targets
N Purchasing products and services N List of substitutable products and services is updated every three years
N Prior approval requirements are in place for high-cost purchases
N Incentivizing consumers N Patients face large out-of-pocket costs for seeking care outside their local clinic
N Patients receive conditional cash transfers for select health-related behaviours
Delivery arrangements
N How care is designed to meet
consumers’ needs
N Local cultural beliefs limit the demand for certain types of programs and services
N Optimal packages of care (e.g., Integrated Management of Childhood Illness) have been adapted to the country
and are widely used
N By whom care is provided N Many parts of the country are experiencing physician shortages
N Community health workers receive high-quality training and supervision to play a defined role in tuberculosis
control
N Where care is provided N Hospitals in urban areas have high-quality infrastructure
N Clinics frequently lack functioning diagnostic equipment and covered/reimbursed medicines
N With what supports is care provided N Information and communication technologies do not function well in rural and remote communities
N Quality monitoring and improvement systems are in place and functioning well
The taxonomy is drawn from Health Systems Evidence (http://www.healthsystemsevidence.org), which is an adapted and more detailed operationalization of the WHO
‘‘building blocks of health systems’’ [15], and the examples are drawn from a range of sources (e.g., [21]). The word ‘‘care’’ within the section of delivery arrangements
could be replaced by programs and services or by prevention, treatment, and support when the focus is more on public health than on clinical care.
doi:10.1371/journal.pmed.1001186.t001
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is to support the type of context-sensitive
policy development at the national level
that we have proposed here.
Certainly, there is a fruitful research
agenda ahead for those interested in
studying the division of responsibilities
across guidance panels at the global level,
EVIPNets or guidance panels at the
national level, and national (or sub-nation-
al) governments, as well as the conditions
under which global organizations have a
legitimate role in making decisions about
health systems. A complementary research
agenda could focus on assessing frame-
works and approaches to supporting system
and political analyses, particularly in the
difficult (but not uncommon) situation
where a health system intervention is
actually a complex bundle of interventions
that can interact in helpful and unhelpful
ways. The results of such research could
inform ongoing modifications to the divi-
sion of labour that we propose in this paper
to ensure that limited resources are used
wisely and that both the best available
research evidence and the contextual
insights of key stakeholders informs guid-
ance development and policy development.
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Table 2. Key features of a political system that can influence decision-making about how to address a health system problem.
Key Features National (or Sub-National) Examples
Institutions
N Government structures N Constitution states that health care is a sub-national responsibility, so provincial finance and health ministries are where most key
decisions are made
N Health minister has delegated authority from the prime minister and cabinet to make almost all key decisions regarding the health
system
N Policy legacies N Legislation created only a limited role for the ministry of health so civil servants never developed the administrative capacities
required to pursue many options
N Health care insurance policy has shaped the thinking and influence of the country’s medical association
N Policy networks N A standing government-appointed guidance panel engages key stakeholders in the process of informing policy-making on select
issues
N A committee comprised of government and medical association representatives makes many recommendations that later become
law
Interests
N Interest groups N For-profit companies that face concentrated benefits or costs in relation to an option mobilize quickly and exert pressure effectively
N Nursing association has the technical and communication staff needed to influence the policy-making process
N Civil society N Citizens are poorly organized and groups representing them have difficulty reaching consensus on their preferred option
N Lack of independent media hampers dialogue and debate
Ideas
N Values N Widely held values support a focus on equity in the health systems
N Government holds a strong pro-market orientation
N Personal experiences N Personal experiences of the minister influence much of her decision-making
N A highly visible consumer representative very effectively mobilizes the stories of individuals’ poor treatment in the system to push for
change
N Research evidence N A systematic review suggests that one option is more effective and cost-effective than others
N A qualitative synthesis identified that stakeholders’ views and experiences are such that one option is likely to achieve higher
coverage rates than others
External factors
N Political change N Election brings a new president or legislative coalition to power
N Cabinet shuffle introduces a new minister to the health portfolio
N Economic change N Global economic crisis reduces donors’ capacity to support national programs
N National economic situation spurs calls to ‘‘do more with less’’
N Release of major reports N A report by a prominent international organization endorses one option over others
N An external audit of a malaria eradication program reveals significant corruption
N Technological change N Mobile phone technology introduces new possibilities for performance management
N New diseases N An influenza outbreak spreads rapidly to other countries
N Media coverage N A series of investigative news articles in the national newspaper reveals the weak enforcement of contracts in the health system
The framework is adapted from one presented elsewhere [22], which in turn was informed by a set of related frameworks (e.g., [23,24]) as well sub-frameworks (e.g.,
[25–28]).
doi:10.1371/journal.pmed.1001186.t002
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